John Militello, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 3,726 shares at $3.31 ($12K) on 2026-02-13, disclosed to the SEC on 2026-02-18.
Seasonal sale ($12k) by See Remarks — this insider has traded RCKT in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RCKT | SELL | 2026-02-20 | $4K | — | Filing → |
| RCKT | SELL | 2025-11-20 | $3K | — | Filing → |
| RCKT | SELL | 2025-10-16 | $193K | — | Filing → |